Available Until 7/30/2025

Opioid De-escalation: Are We Exceeding the Speed Limit?

ACPE Activity Number: 0204-0000-22-045-H01-P
Release Date: July 30, 2022
Expiration Date: July 30, 2025
Activity Type: Knowledge-based
CE Credits:  0.25 contact hour, no partial credit
Activity Fee: Member – Free / Non-Member – Not Available 

Activity Overview 

Pharmacists who treat patients with opioids are aware of the CDC guidelines that recommended opioid tapering in various patient populations.  However, the guidelines did not explain how to appropriately taper opioids.  Patients on higher doses/long term therapy were being made to involuntarily taper opioids quickly, leading to potential harm, as demonstrated in recent literature.  By understanding appropriate opioid tapering processes, and the need for patient cooperation with the plan, pharmacists can help decrease opioid dosages while mitigating harm.  

The American Society of Health-System Pharmacists is accredited by the Accreditation Council for Pharmacy Education as a provider of continuing pharmacy education.

These activities were planned to meet the educational needs of pharmacists who are interested in opioid descalation strategies in the hospital and ambulatory care setting.

After participating in this CPE activity, participants should be able to:

  • Describe an appropriate opioid taper based on patient specific factors and therapy duration.
  • Identify the risks of tapering opioids too rapidly. 

  • Introduction and Announcements 

  • Presentation  

Gretchen Lindsey, PharmD
VP Clinical Services at Comprehensive Pharmacy Services
Powell, Ohio

Maria Foy, PharmD, BCPS, CPE
Pharmacy Care Coordinator, Palliative Care
Jefferson Abington Health
Abington, PA

Jenny Koehl, BCPS
Emergency Medicine Clinical Specialist
Massachusettes General Hospital
Boston, MA

In accordance with our accreditor’s Standards of Integrity and Independence in Accredited Continuing Education, ASHP requires that all individuals in control of content disclose all financial relationships with ineligible companies. An individual has a relevant financial relationship if they have had a financial relationship with an ineligible company in any dollar amount in the past 24 months and the educational content that the individual controls is related to the business lines or products of the ineligible company. 

An ineligible company is any entity producing, marketing, re-selling, or distributing health care goods or services consumed by, or used on, patients. The presence or absence of relevant financial relationships will be disclosed to the activity audience. 

  • No one in control of the content of this activity has a relevant financial relationship (RFR) with an ineligible company. 

Per ACPE requirements, CPE credit must be claimed within 60 days of being earned. Once you have processed and claimed your CE credit, we encourage you to check your NABP eProfile account to verify your credits were transferred successfully before the ACPE 60-day deadline. It is an electronic direct-report process so your credits should appear in your account within a few minutes. After the 60 day deadline, ASHP will no longer be able to report your credit(s) for this activity.